The promise of autonomous agentic AI requires significant changes in the governance landscape. Provided byIntel Parents of ...
During a live event, Nataliya Mar, MD, discussed systemic therapies such as lenvatinib/pembrolizumab in advanced renal cell carcinoma based on recent trials. Renal cell carcinoma (RCC) treatment has ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved Hernexeos for adults with unresectable or metastatic HER2-mutant NSCLC. It received accelerated ...
Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes. HealthDay News — Men with nonmetastatic prostate cancer receiving ...
XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...
Dr Jonathan Goldman, of the University of California, Los Angeles, shares key updates in metastatic non-small cell lung cancer from ASCO 2025. Dr Goldman reviews findings from TROPION-Lung02, which ...
Community driven content discussing all aspects of software development from DevOps to design patterns. Instance main methods and unnamed classes, coming in Java 21, will forever change how developers ...
Healthier lifestyles were associated with improved overall survival but not prostate cancer–specific survival in a multiethnic cohort of patients with nonmetastatic prostate cancer. Behavioral scores ...
Neoadjuvant TKI therapy in non-metastatic GIST patients can reduce surgical complexity, with CE-CT imaging predicting benefits in 22 of 39 patients. Significant tumor volume reduction was observed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results